In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside

Acta Haematologica

Volumn 104, Issue 2-3, 2000, Pages 57-64

  Stagno, Fabio ^a   Guglielmo, Patrizia ^a   Consoli, Ugo ^a   Inghilterra, Giovanna ^a   Giustolisi, Giada Maria ^a   Palumbo, Giuseppe Alberto ^a   Giustolisi, Rosario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

All trans retinoic acid; Apoptosis; Chronic myeloid leukemia; Cytosine arabinoside; Programmed cell death

Indexed keywords

BCR ABL PROTEIN; CYTARABINE; RETINOIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL ISOLATION; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL DIFFERENTIATION; CELL SEPARATION; CYTARABINE; DNA FRAGMENTATION; ELECTROPHORESIS, AGAR GEL; FEMALE; GRANULOCYTES; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, CHRONIC-PHASE; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; TRETINOIN; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034515732     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000039753     Document Type: Article

References (35)

1. Prolonged survival in chronic myelogenous leukemia following cytogenetic response to alpha-interferon therapy
2. Interferon-α versus conventional chemotherapy
3. Chronic myelogenous leukaemia: Recent advances
4. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death
5. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
6. Retinoids in cancer therapy
7. Chemoprevention of cancer with retinoids
8. Retinoids as chemopreventive agents for breast cancer
9. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid)
10. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship
11. All-trans retinoic acid in hematological malignancies: An update
12. A pilot study of all-trans retinoic acid (ATRA) in patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML)
13. Treatment of acute nonlymphocytic leukemia: Use of anthracyclines-cytosine arabinoside induction therapy and comparison of two maintenance regimens
14. Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
15. Does treatment with Ara-C in low dosage cause differentiation of leukemic cells?
16. Low-dose cytarabine for acute myeloid leukemia and myelodisplastic syndromes: In vivo and in vitro cytotoxicity
17. Induction of DNA strand breaks associated with apoptosis during treatment of leukemia
18. Preferential inhibition by citarabine of CFU-GM from patients with chronic granulocytic leukemia
19. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside
20. Cancer combination chemotherapy with retinoids: Experimental rationale
21. Differential kinetic of propidium iodide uptake in apoptotic and necrotic thymocytes
22. Features of apoptotic cells measured by flow cytometry
23. Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation
24. All-trans retinoic acid (ATRA) induced apoptosis in peripheral freshly isolated chronic myeloid leukemia cells
25. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside: Application to the study of regulated drug sensitivity
26. Arabynosyl cytosine in chronic myeloid leukemia: Evidence for high cytokinetic sensitivity of myeloblasts
27. Preferential inhibition by cytarabine of CFU-GM from patients with chronic granulocytic leukemia
28. Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative disease: Increased sensitivity in blast phase of chronic myeloid leukemia
29. Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: Increased inhibition by all-trans and 13-cis retinoic acid in advanced stage disease
30. All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia
31. All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro
32. In vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis
33. All-trans retinoic acid- and growth factor-mediated induction of alkaline phosphatase activity in freshly isolated chronic myeloid leukemia cells
34. All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase
35. Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine